The most recent HAART treatments contain two reverse transcriptase inhibitors and a third drug from another class, usually a protease inhibitor or an integrase inhibitor. (newscientist.com)
Two of the drugs are investigational and approved by the Food and Drug Administration (FDA) for use in people as part of clinical trials; the third drug is FDA - approved to treat rheumatoid arthritis. (sciencedaily.com)
When combined with darunivir and a third drug, it led to undetectable virus in 82 percent of 82 patients, according to the study. (scientificamerican.com)